Journals / Solunum / 2012 / Cilt: 14 - Sayı: 1

Genetic risk factors in chronic obstructive pulmonary disease

Kronik obstrüktif akciğer hastalığında genetik risk faktörleri

Journal
Solunum
Pages
1–5
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No doubt that the role of genetics on COPD development will continue to be one of the important research issues in future too.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The role of genetic factors in development of chronic obstructive pulmonary disease (COPD) is accepted in general.
📊
Key Findings & Data:However, other than α-1 antitrypsin deficiency which alone can lead to COPD, the studies performed longer than half a century did not yield any certain result on the genetics of COPD.
💡
Conclusion & Impact:No doubt that the role of genetics on COPD development will continue to be one of the important research issues in future too.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The role of genetic factors in development of chronic obstructive pulmonary disease (COPD) is accepted in general. However, other than α-1 antitrypsin deficiency which alone can lead to COPD, the studies performed longer than half a century did not yield any certain result on the genetics of COPD. Regarding the data available, it can be said that addition of environmental factors like cigarette smoking on interrelations between genetic abnormalities are responsible for COPD development. No doubt that the role of genetics on COPD development will continue to be one of the important research issues in future too.

Özet

Kronik obstrüktif akciğer hastalığı (KOAH) oluşumunda genetik faktörlerin rolünün önemli olduğu fikri genel olarak kabul edilmektedir. Bununla birlikte, yarım asırdan uzun süredir yapılan birçok çalışmadan α-1 antitripsin eksikliğinin tek başına KOAH’a yol açabileceği bilgisi dışında kesin bir sonuç elde edilememiştir. Elimizdeki veriler ışığında, birçok gen bozuklukları arasındaki etkileşimlerin üstüne eklenen sigara dumanı gibi çevresel faktörlerin KOAH oluşumdan sorumlu olduğu söylenebilir. Şüphesiz gelecekte de KOAH oluşumunda genetik risk faktörleri, üzerinde en fazla çalışılan konulardan biri olmaya devam edecektir.

🔖

Cite This Article

MUTLU, L. C., GÜLBAŞ, G., GÜNEN, H. (2012). Genetic risk factors in chronic obstructive pulmonary disease. Solunum, Cilt: 14 - Sayı: 1, 1–5. https://ajindex.com/articles/314335

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. http://www.who.int/respiratory/copd/burden/en/index.html (24.03.2010
  2. Gunen H, Hacievliyagil SS, Yetkin O, Gulbas G, Mutlu LC, Pehlivan E. Prevalence of COPD: first epidemiological study of a large region in Turkey. Eur J Intern Med 2008;19:499-504
  3. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance–United States, 1971- 2000. MMWR Surveill Summ 2002;51:1-16
  4. Oulette DR. The answer is fifteen percent: what is the question? Chest 2004;125:3-5
  5. Global Initiative for Chronic Obstructive Lung Disease. Definition. Global Strategy for the diagnosis, management, and prevention of Chronic Obstructive Lung Disease 2006;1-6
  6. Kueppers F, Miller RD, Gordon H, Hepper NG, Offord K. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med 1977;63:336-342
  7. Redline S, Tishler PV, Rosner B, Lewitter FI, Vandenburgh M, Weiss ST, et al. Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins. Am J Epidemiol 1989;129:827-836
  8. Carrozzi L, Rijcken B, Burney P, DeGraaf A, et al. Family history for chronic lung diseases and epidemiological determinants of COPD in three European countries. Eur Respir Rev 2001;11:49-54
  9. Silverman EK. Genetic epidemiology of COPD. Chest 2002; 121:1-6
  10. Needham M, Stockley RA: Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history. Thorax 2004,59:441-445
  11. Potempa I, Korzus E, Travis I. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem 1994; 269:15957-15960
  12. Tobin MJ, Cook PJL, Hutchinson DCS. Alpha 1-antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association. Br J Dis Chest 1983;77:14–27
  13. Wood AM, Stockley RA. The genetics of chronic obstructive pulmonary disease. Respir Res 2006;7:130:1-14
  14. Sandford AJ, Chagani T, Weir TD, Connett JE, Anthonisen NR, Paré PD. Susceptibility genes for rapid decline of lung function in the Lung Health Study. Am J Respir Crit Care Med 2001;163:469-473
  15. Silva GE, Sherrill DL, Guerra S, Barbee RA. A longitudinal study of α1-antitrypsin phenotypes and decline in FEV1 in a community population. Chest 2003;123:1435-1440
  16. Demeo DL, Mariani TJ, Lange C, Srisuma S, Litonjua AA, Celedon JC, et al. The SERPINE2 gene is associated with chronic obs